Sleep apnea is a genuine rest issue that happens when a man’s breathing is hindered amid rest. Individuals with untreated rest apnea quit breathing over and over amid their rest, in some cases several times. This implies the mind – and whatever remains of the body – may not get enough oxygen.
Factors such as increase in the prevalence of sleep apnea globally is majorly driving the growth of the market. As per to the National Commission on Sleeping Disorders Research, globally about 38,000 deaths are occurring annually owing to the cardiovascular problems associated with sleepapnea. Furthermore, growing geriatric population, rising lifestyle changes, growing homecare acceptance, growing awareness about health, sleep disorders, improving healthcare infrastructure, introduction of new technologies and innovative products are the few factors which are boosting the growth of the market. However, strict regulatory procedures, side effects associated with the drugs, high competition in the market are the factors which are hampering the sleep apnea diagnostic systems growth.
The Sleep Apnea Diagnostic Systems Market is classified on the basis of diagnostic type, end user and geographical regions.
Based on Diagnostic Type,Global Market is segmented into
- Actigraphy System
- Polysomnography Device (PSG)
- Respiratory Polygraph
- Single-Channel Screening Devices (Pulse Oximeter )
Based on End User, Global Market is segmented into
- Sleep Laboratories
- Home Care/Individuals
- Rest of Europe
- Australia & New Zealand
- ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
- South Korea
- Rest of Asia-Pacific
- Rest of Latin America
Middle East and Africa (MEA)
- Gulf Cooperation Council (GCC) Countries
- South Africa
- Rest of MEA
Increasing number of rehabilitation centres, awareness campaigns to assist patients with neurological disorders which has led to rise in number of patients seeking treatments for neurological disorders. The risk of sleep apnea is greater in age group of 50-60 years. According to UNO estimations in 2012, geriatric population was about 810Mn and it is anticipated to grow over 2000Mn people by 2050 globally. Expanded spotlight on R&D exercises for creating inventive items and key activities, for example, merger and securing and new item dispatch is the significant system embraced by these players to keep up their market position. For example, In May 2017, Philips consented to securing arrangement with Respiratory Technologies, Inc. The obtaining will grow Philips sleep and respiratory care business.
Geographically Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America dominated the market followed by Asia-Pacific and Europe. The factors attributable for North America are having high obesity rates while Europe has large population pool suffering with diabetic retinopathy. Owing to improved infrastructure and awareness among the people especially of emerging markets like China, India and Brazil, there is strong emphasis on the quality of life (QALY) for diabetic patients demanding early detection and treatment of chronic, the market seems to be agile and open.
- Koninklijke Philips (Netherlands)
- ResMed (US)
- Fisher & Paykel Healthcare (New Zealand)
- SomnoMed (Australia)
- Löwenstein Medical (Germany)
- Compumedics (Australia)
- Whole You (US)
- Drive DeVilbiss Healthcare (US)
- BMC Medical (China)
- Braebon Medical (Canada)